Justin Crowther

Justin Crowther
T: +44 (0) 115 957 8236
T: +44 (0) 20 7246 0500
E: justincrowther@catalystcf.co.uk

Justin is a Partner and has over 15 years of successful transaction advisory experience at Catalyst.

Justin leads Catalyst's Healthcare sector team. Recent transactions include the merger of Options Group with Outcomes First Group, the sales of Raphael HealthcareFocus Pharmaceuticals, the ARX Group, Williams Medical Supplies and Solor Care, and the management buy-outs of 4Ways Healthcare and NRS.

He regularly writes for the sector's leading publications including HealthInvestor and Caring Times, and is often sought out by the national press, including the Financial Times, for his opinions. Justin is also one of the authors of the Catalyst Pharma Fast 50.

Born and bred in Nottingham, Justin leads our presence with Simon Peacock in the East Midlands market, using his extensive connections with the region's corporate mid-market and intermediary professionals.

A graduate of Newcastle University, Justin trained as a chartered accountant with KPMG before moving onto the corporate development team of the then FTSE 100 company, Boots plc. Justin joined Catalyst in 2000.

A member of the Catalyst 'two daughters' club, Justin combines his family duties with honing his tennis skills and taking as many opportunities as possible to play golf.

Healthcare deals of 2015 - 4Ways and Quotient Clinical

This year has been another extremely active period for M&A and private equity activity across the healthcare sector... 

Pharmaceutical M&A volumes triple in 2015

Pharmaceutical M&A activity involving UK companies has tripled in 2015. There has been a significant number of large cross-border deals and private equity investment...  

Top 5 healthcare deals of 2015

The first half of 2015 has seen overall M&A activity increase. Activity has been particularly notable in pharmaceutical services...  

The future of the NHS, centre stage!

The future of the NHS is receiving huge coverage across multiple media channels following the major speech yesterday by… 

Overseas investors targeting growth opportunities in UK healthcare services

September has been another busy month for healthcare deals, confirming a number of trends discussed in our latest  

Catalyst hosts Q&A with West Midlands mayoral candidate Andy Street

Catalyst has hosted a Q&A with West Midland’s mayoral candidate Andy Street, at its Birmingham Office.  

Catalyst has advised the shareholders of UK Heating Group, including Encore Capital, on the sale to Irsap Group

Catalyst Corporate Finance has advised the shareholders of UK Heating Group, including Encore Capital, on the sale to Irsap Group. 

Catalyst advises the shareholders of Thompson & Morgan on the sale to BVG Group

Catalyst has advised the shareholders of Thompson & Morgan Group Holdings, including Primary Capital, on the sale to BVG Group 

Catalyst advises Phoenix Equity Partners on its investment in Global Freight Solutions

Catalyst has advised Phoenix Equity Partners on its investment in Global Freight Solutions (Holdings) Ltd (GFS) alongside the current management team, led by CEO Neil Cotty. 

Catalyst appoints two new principals

Catalyst Corporate Finance has expanded its dealmaking team with the recruitment of Alex Silk and Shannon Cox who join the firm as Principals.